|
|
|
|
Clinical Trials
- O(6)-benzylguanine and Carmustine in Treating Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00002604 - Completed
unspecified adult solid tumor, protocol specific
- O(6)-benzylguanine and Carmustine in Treating Patients With Stage I or Stage II Cutaneous T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00003613 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
- O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
ClinicalTrials.gov Identifier: NCT00436436 - Recruiting
Brain and Central Nervous System Tumors
- O(6)-benzylguanine in Treating Patients With Malignant Glioma
ClinicalTrials.gov Identifier: NCT00002971 - Completed
adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
- O6-benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
ClinicalTrials.gov Identifier: NCT00004892 - Completed
Adult Oligodendroglioma; recurrent adult brain tumor; adult glioblastoma multiforme; adult ependymoma; adult anaplastic astrocytoma; ...
- O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
ClinicalTrials.gov Identifier: NCT00003765 - Active, not recruiting
recurrent childhood brain stem glioma; childhood choroid plexus tumor; recurrent childhood visual pathway glioma; ...
- O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004072 - Completed
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
ClinicalTrials.gov Identifier: NCT00005066 - Active, not recruiting
stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma
- O6-benzylguanine and Carmustine in Treating Patients with Unresectable Locally Recurrent or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00005961 - Completed
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors
ClinicalTrials.gov Identifier: NCT00275002 - Recruiting
Recurrent Childhood Brain Stem Glioma; Recurrent Childhood Brain Tumor; High-Grade Childhood Cerebral Astrocytoma; ...
- O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery
ClinicalTrials.gov Identifier: NCT00003766 - Completed
unspecified adult solid tumor, protocol specific
- OASIS Mechanism of Action
ClinicalTrials.gov Identifier: NCT00570141 - Enrolling by invitation
Diabetic Foot Ulcers; Venous Stasis Ulcers
- OASIS STUDY( Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS STUDY)
ClinicalTrials.gov Identifier: NCT00281034 - Completed
Stroke
- Oasys vs. Extreme H20 Xtra 59
ClinicalTrials.gov Identifier: NCT00477763 - Recruiting
Dry Eye
- Oatmeal and Insulin Resistance
ClinicalTrials.gov Identifier: NCT00401453 - Recruiting
Diabetes Mellitus Type 2; Insulin Resistance
- Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma
ClinicalTrials.gov Identifier: NCT00538187 - Not yet recruiting
Lymphoma
- Obatoclax Mesylate and Topotecan in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00521144 - Recruiting
Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Obatoclax Mesylate, Fludarabine and Rituximab in Previously Treated Patients With B-CLL
ClinicalTrials.gov Identifier: NCT00574938 - Recruiting
Chronic Lymphocytic Leukemia
- OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
ClinicalTrials.gov Identifier: NCT00577031 - Not yet recruiting
Colorectal Cancer
- Obese Hypertension Study
ClinicalTrials.gov Identifier: NCT00289887 - Active, not recruiting
Hypertension
- Obese Patients with or without Comorbidities
ClinicalTrials.gov Identifier: NCT00029861 - Completed
Obesity; Weight Loss
- Obese Patients with Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00029848 - Completed
Obesity; Diabetes Mellitus, Non-Insulin-Dependent; Obesity in Diabetes
- Obese Patients with Untreated Dyslipidemias
ClinicalTrials.gov Identifier: NCT00029835 - Completed
Obesity; Dyslipidemia
- Obesity and Asthma:a Specific Phenotype
ClinicalTrials.gov Identifier: NCT00532363 - Active, not recruiting
Obesity; Asthma
- Obesity and Diabetes Prevention Through Science Enrichment
ClinicalTrials.gov Identifier: NCT00541879 - Recruiting
Type 2 Diabetes; Obesity
- Obesity and Free Fatty Acid Flux
ClinicalTrials.gov Identifier: NCT00074945 - Recruiting
Obesity
- Obesity and Nonalcoholic Fatty Liver Disease
ClinicalTrials.gov Identifier: NCT00262964 - Recruiting
Non-Alcoholic Fatty Liver Disease
- Obesity and Weight Loss on Reproductive Function
ClinicalTrials.gov Identifier: NCT00143078 - Recruiting
Obesity; Reproductive System
- Obesity Assessment and Education Through the Internet
ClinicalTrials.gov Identifier: NCT00149682 - Completed
Obesity
- Obesity Intervention "Obeldicks" for Obese Children, Adolescents and Their Parents
ClinicalTrials.gov Identifier: NCT00435734 - Recruiting
Obesity
- Obesity Prevention after Smoking Cessation in Menopause
ClinicalTrials.gov Identifier: NCT00064961 - Completed
Obesity; Menopause
- Obesity Prevention for Pre-Adolescents
ClinicalTrials.gov Identifier: NCT00185978 - Completed
Cardiovascular Diseases; Heart Diseases; Obesity
- Obesity Prevention in African American School Children
ClinicalTrials.gov Identifier: NCT00061165 - Completed
Obesity
- Obesity Treatment in a Managed Care Setting
ClinicalTrials.gov Identifier: NCT00062985 - Completed
Obesity; Weight Loss
- Obesity, Physical Inactivity or Dietary Fat ?
ClinicalTrials.gov Identifier: NCT00434265 - Not yet recruiting
Obesity
- Obesity, Weight Loss, and Cardiovascular Disease Risk
ClinicalTrials.gov Identifier: NCT00186459 - Recruiting
Obesity
- Objective Evaluation of Proximal Ischemia
ClinicalTrials.gov Identifier: NCT00152737 - Recruiting
Intermittent Claudication; Peripheral Vascular Diseases
- Objective Evaluation of Shoulder Pathology and Surgery
ClinicalTrials.gov Identifier: NCT00500630 - Completed
Glenohumeral Osteoarthritis; Rotator Cuff Disease
- Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
ClinicalTrials.gov Identifier: NCT00567177 - Recruiting
Treatment of Dry Eye Disease
- Objective Sleep Disturbances in Orthostatic Intolerance
ClinicalTrials.gov Identifier: NCT00581022 - Recruiting
Postural Tachycardia Syndrome; Chronic Orthostatic Intolerance
- Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
ClinicalTrials.gov Identifier: NCT00070343 - Active, not recruiting
Stage IV Melanoma; stage III melanoma
- Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
ClinicalTrials.gov Identifier: NCT00047229 - Active, not recruiting
adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
- Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma
ClinicalTrials.gov Identifier: NCT00060112 - Suspended
adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma
- Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00017589 - Active, not recruiting
recurrent adult acute myeloid leukemia
- Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00091078 - Active, not recruiting
gastrointestinal stromal tumor
- Oblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00059813 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Oblimersen and Rituximab in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00054639 - Active, not recruiting
adult non-Hodgkin's lymphoma
- Oblimersen in Treating Patients With Metastatic or Recurrent Merkel Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00079131 - Completed
recurrent Merkel cell carcinoma; stage II Merkel cell carcinoma; stage III Merkel cell carcinoma
- Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00021190 - No longer recruiting
stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
- Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00062244 - Completed
Waldenstrom's Macroglobulinemia
- Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors
ClinicalTrials.gov Identifier: NCT00039481 - Completed
cardiac toxicity; unspecified childhood solid tumor, protocol specific
- Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00063934 - Active, not recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; Male Breast Cancer
- Oblimersen Plus Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00049192 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
- Oblimersen, Cisplatin, and Fluorouracil in Treating Patients With Advanced Esophageal, Gastroesophageal Junction, or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00064259 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00039117 - Active, not recruiting
untreated adult acute myeloid leukemia; secondary acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); ...
- Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00086944 - Active, not recruiting
recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma; recurrent grade 3 follicular lymphoma
- Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00070083 - Completed
contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ...
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
refractory plasma cell neoplasm
- Observation and Evaluation of Chewing Velocity Changes on Soft Food Chewing Efficiency
ClinicalTrials.gov Identifier: NCT00172692 - Completed
Healthy; Mastication
- Observation and Prediction of Complications After Coronary Angiography
ClinicalTrials.gov Identifier: NCT00259194 - Active, not recruiting
Coronary Arteriosclerosis; Myocardial Ischemia
- Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
ClinicalTrials.gov Identifier: NCT00274950 - Recruiting
Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Ovarian Cancer
- Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9
ClinicalTrials.gov Identifier: NCT00400907 - Active, not recruiting
Long-Term Effects Secondary to Cancer Therapy in Adults; Lymphoma
- Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor
ClinicalTrials.gov Identifier: NCT00001826 - Completed
HIV Infection
- Observation of Respiration Following Regional Anaesthesia With Intrathecal Opioids for Caesarean Section
ClinicalTrials.gov Identifier: NCT00544947 - Not yet recruiting
Respiratory Depression
- Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
ClinicalTrials.gov Identifier: NCT00258453 - Active, not recruiting
Brain and Central Nervous System Tumors; Long-Term Effects Secondary to Cancer Therapy in Children; Perioperative/Postoperative Complications; Psychosocial Effects/Treatment; Quality of Life; Weight Changes
- Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only
ClinicalTrials.gov Identifier: NCT00416559 - Active, not recruiting
Long-Term Effects Secondary to Cancer Therapy in Children; Neuroblastoma
- Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
ClinicalTrials.gov Identifier: NCT00027846 - Active, not recruiting
childhood supratentorial ependymoma; newly diagnosed childhood ependymoma; childhood infratentorial ependymoma
- Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
ClinicalTrials.gov Identifier: NCT00003375 - Active, not recruiting
Adult Oligodendroglioma; adult noninfiltrating astrocytoma; adult infiltrating astrocytoma
- Observation or Radical Treatment in Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00499174 - Recruiting
Prostate Cancer
- Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism
ClinicalTrials.gov Identifier: NCT00193661 - Completed
Primary or Secondary Hypogonadism; Constitutional Delay in Growth and Puberty (CDGP)
- Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
ClinicalTrials.gov Identifier: NCT00410631 - Recruiting
Brain and Central Nervous System Tumors
- Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
ClinicalTrials.gov Identifier: NCT00346164 - Recruiting
Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
- Observational Aspirin Use and CVD in the Physicians' Health Study
ClinicalTrials.gov Identifier: NCT00005493 - Completed
Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Infarction; Cerebrovascular Accident
- Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
ClinicalTrials.gov Identifier: NCT00316732 - Active, not recruiting
Benign Prostatic Hyperplasia
- Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
ClinicalTrials.gov Identifier: NCT00433030 - Recruiting
HIV Infections
- Observational Cohort Study of Sodium, Weight and CVD
ClinicalTrials.gov Identifier: NCT00006308 - Active, not recruiting
Cardiovascular Diseases; Heart Diseases; Hypertension
- Observational Cohort Study of TachoSil
ClinicalTrials.gov Identifier: NCT00285623 - Active, not recruiting
Blood Loss, Surgical
- Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products
ClinicalTrials.gov Identifier: NCT00388947 - Recruiting
Vaginal Prolapse
- Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury
ClinicalTrials.gov Identifier: NCT00498498 - Recruiting
Cerebrovascular Trauma; Neurohormones; Cellular Apoptosis; Endothelin System
- Observational FAP Registry Study
ClinicalTrials.gov Identifier: NCT00151476 - Recruiting
Adenomatous Polyposis Coli
- Observational Learning in Stroke Patients
ClinicalTrials.gov Identifier: NCT00083642 - Active, not recruiting
- Observational Non-Interventional Study (Anwendungsbeobachtung) With Aptivus? (Tipranavir) in HIV-Infected Patients.
ClinicalTrials.gov Identifier: NCT00531206 - Recruiting
HIV Infections
- Observational Non-Interventional Study (Anwendungsbeobachtung) With Telmisartan in High-Risk Hypertensives
ClinicalTrials.gov Identifier: NCT00539487 - Recruiting
Hypertension; Obesity
- Observational Non-Interventional Study With Spiriva in COPD Patients With Exercise-Induced Dyspnoea
ClinicalTrials.gov Identifier: NCT00540163 - Completed
Chronic Obstructive Pulmonary Disease
- Observational Non-Interventional Study With Viramune? in Combination With Truvada? in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00543803 - Recruiting
HIV Infections
- Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment
ClinicalTrials.gov Identifier: NCT00358813 - Recruiting
Renal Impairment
- Observational Safety Study of Enbrel for Treatment of Psoriasis
ClinicalTrials.gov Identifier: NCT00322439 - Completed
Psoriasis
- Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
ClinicalTrials.gov Identifier: NCT00359177 - Completed
Renal Impairment
- Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
ClinicalTrials.gov Identifier: NCT00242840 - Completed
HIV Infections
- Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov Identifier: NCT00259909 - Completed
Chronic Obstructive Pulmonary Disease
- Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
ClinicalTrials.gov Identifier: NCT00549952 - Recruiting
Oral Mucositis
- Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults
ClinicalTrials.gov Identifier: NCT00331448 - Active, not recruiting
HIV Infections; Lipodystrophy; Diabetes; Hyperlipidemia; Atherosclerosis
- Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
ClinicalTrials.gov Identifier: NCT00119405 - Recruiting
HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders
- Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide
ClinicalTrials.gov Identifier: NCT00202657 - Active, not recruiting
Parkinson's Disease; Pergolide
- Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
ClinicalTrials.gov Identifier: NCT00514098 - Not yet recruiting
HIV Infections
- Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus
ClinicalTrials.gov Identifier: NCT00321438 - Terminated
HIV Infections
- Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year
ClinicalTrials.gov Identifier: NCT00550069 - Not yet recruiting
Respiratory Distress; Hypoglycemia; Feeding Intolerance; Jaundice; Hypothermia; Developmental Delay
- Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide
ClinicalTrials.gov Identifier: NCT00569907 - Recruiting
Diabetes Mellitus Type 2
- Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients
ClinicalTrials.gov Identifier: NCT00338234 - Recruiting
Anemia; Intensive Care; Cardiac Surgery
- Observational Study of Lamotrigine
ClinicalTrials.gov Identifier: NCT00299793 - Completed
Epilepsy
- Observational Study of Pergolide Mesylate and Cardiac Valvulopathy
ClinicalTrials.gov Identifier: NCT00311532 - Completed
Parkinson Disease
- Observational Study of Prosthetic Tissue Aortic and Mitral Heart Valve
ClinicalTrials.gov Identifier: NCT00329667 - Active, not recruiting
Valvular Heart Disease
- Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
ClinicalTrials.gov Identifier: NCT00258869 - Recruiting
Sepsis; Septicemia; Sepsis Syndrome; Shock, Septic; Pneumonia
- Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.
ClinicalTrials.gov Identifier: NCT00158717 - Active, not recruiting
Hepatitis B
- Observational Study of the Prognosis in Treated Arterial Hypertension
ClinicalTrials.gov Identifier: NCT00225030 - Completed
Hypertension
- Observational Study of the Remodelling Process Following Myocardial Infarct
ClinicalTrials.gov Identifier: NCT00338156 - Completed
Heart Failure; Myocardial Infarct
- Observational Study of Treated and Untreated Acute and Early HIV-1 Infection
ClinicalTrials.gov Identifier: NCT00219934 - Recruiting
HIV Infections
- Observational Study Regarding Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma Outpatients
ClinicalTrials.gov Identifier: NCT00557141 - Not yet recruiting
Asthma
- Observational Study to Determine Impact of Multiple NAb Tests on Treatment Patterns Compared to the Usual Care of MS Patients Receiving High-Dose IFN Therapy.
ClinicalTrials.gov Identifier: NCT00336557 - Recruiting
Multiple Sclerosis
- Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe
ClinicalTrials.gov Identifier: NCT00457275 - Completed
Hypercholesterolemia
- Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
ClinicalTrials.gov Identifier: NCT00244465 - Recruiting
Narcolepsy
- Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
ClinicalTrials.gov Identifier: NCT00347217 - Recruiting
Hypercholesteremia
- Observational Trial With Enbrel
ClinicalTrials.gov Identifier: NCT00488475 - Recruiting
Rheumatoid Arthritis
- Observational Trial With Leios/Alesse
ClinicalTrials.gov Identifier: NCT00481650 - Completed
Contraceptives, Oral, Combined
- Observing Patients with Early HIV Infection
ClinicalTrials.gov Identifier: NCT00005020 - Active, not recruiting
HIV Infections
- Obstetrics and Periodontal Therapy (OPT) Study
ClinicalTrials.gov Identifier: NCT00066131 - Active, not recruiting
Periodontitis; Infant, Premature
- Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress
ClinicalTrials.gov Identifier: NCT00177892 - Recruiting
Obstructive Sleep Apnea; Metabolic Syndrome X
- Obstructive Sleep Apnea Syndrome in Glaucoma
ClinicalTrials.gov Identifier: NCT00313092 - Recruiting
Obstructive Sleep Apnoe Syndrome; Glaucoma
- Obtain a Good Blood Glucose Control With the Paradigm Real Time System
ClinicalTrials.gov Identifier: NCT00441129 - Recruiting
Type 1 Diabetes
- Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.
ClinicalTrials.gov Identifier: NCT00200109 - Active, not recruiting
Chronic Migraine Headache
- Occipital Nerve Stimulation to Treat Chronic Headaches
ClinicalTrials.gov Identifier: NCT00205894 - Active, not recruiting
Headache Disorders
- Occluded Artery Trial (OAT)
ClinicalTrials.gov Identifier: NCT00004562 - Active, not recruiting
Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Heart Failure, Congestive; Heart Failure
- Occupation and Asthma in an Urban Low Income Population
ClinicalTrials.gov Identifier: NCT00014820 - Completed
Asthma; Lung Diseases
- Occupational Therapy to Treat Children Who Over or Under React to Their Environment
ClinicalTrials.gov Identifier: NCT00006507 - Completed
Sensory Disorders
- Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the Highly Active Antiretroviral Therapy
ClinicalTrials.gov Identifier: NCT00516581 - Completed
Pneumocystis Pneumonia; HIV Infections
- OCD Among Patients With Burns
ClinicalTrials.gov Identifier: NCT00294983 - Suspended
Obsessive-Compulsive Dosorder; Burns
- OCSTUD Docetaxel+Cisplatin+Cyclophosphamide Versus Docetaxel+Carboplatin in Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00452985 - Active, not recruiting
Ovarian Neoplasms
- OCT for Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer
ClinicalTrials.gov Identifier: NCT00581503 - Enrolling by invitation
Lung Cancer; Pleural Cancer; Prostate Cancer
- Octanol to Treat Essential Tremor
ClinicalTrials.gov Identifier: NCT00080366 - Completed
Essential Tremor
- Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00008073 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
ClinicalTrials.gov Identifier: NCT00569127 - Not yet recruiting
Head and Neck Cancer; Islet Cell Tumor; Neuroendocrine Carcinoma of the Skin
- Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00004895 - Completed
Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer
- Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
ClinicalTrials.gov Identifier: NCT00332696 - Active, not recruiting
Peritoneal Neoplasms; Intestinal Obstruction; Carcinomatosis
- Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00003057 - Active, not recruiting
Colon Cancer; Diarrhea; Rectal Cancer
- Octreotide Efficacy and Safety in First-Line Acromegalic Patients
ClinicalTrials.gov Identifier: NCT00171886 - Suspended
Acromegaly
- Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
ClinicalTrials.gov Identifier: NCT00033605 - Active, not recruiting
adult solid tumor; Diarrhea; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; male reproductive cancer
- Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
ClinicalTrials.gov Identifier: NCT00075868 - Active, not recruiting
Anal Cancer; Drug Toxicity; radiation enteritis; Rectal Cancer
- Octreotide in Severe Polycystic Liver Disease
ClinicalTrials.gov Identifier: NCT00426153 - Recruiting
Polycystic Kidney, Autosomal Dominant; Hepatomegaly; Liver Diseases; Kidney, Polycystic; Abdominal Pain
- Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
ClinicalTrials.gov Identifier: NCT00006269 - Active, not recruiting
recurrent colon cancer; Diarrhea; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
- Octreotide in Treating Patients With Cancer-Related Malignant Ascites
ClinicalTrials.gov Identifier: NCT00182754 - Recruiting
unspecified adult solid tumor, protocol specific; malignant ascites
- Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
ClinicalTrials.gov Identifier: NCT00257426 - Active, not recruiting
Liver Cancer
- Octreotide Therapy in Children With Prader-Willi Syndrome (PWS)
ClinicalTrials.gov Identifier: NCT00399893 - Recruiting
Prader-Willi Syndrome
- Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
ClinicalTrials.gov Identifier: NCT00003283 - Active, not recruiting
recurrent malignant thymoma; invasive malignant thymoma
- Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00002967 - Completed
stage I breast cancer; invasive ductal breast carcinoma; stage II breast cancer
- Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment with Dorzolamide
ClinicalTrials.gov Identifier: NCT00152932 - Recruiting
Laser-Doppler Flowmetry
- Ocular Hypertension Treatment Study (OHTS)
ClinicalTrials.gov Identifier: NCT00000125 - Active, not recruiting
Ocular Hypertension; Glaucoma
- Ocular Hypotensive Efficacy of AR-102
ClinicalTrials.gov Identifier: NCT00523250 - Recruiting
Glaucoma
- Ocular Ischemic Syndrome
ClinicalTrials.gov Identifier: NCT00403195 - Recruiting
Retinal Degeneration; Diabetic Retinopathy
- Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00356850 - Completed
Eye Infections, Bacterial
- Ocular Pulse Amplitude And Choroidal Laser Doppler Flowmetry
ClinicalTrials.gov Identifier: NCT00409110 - Recruiting
Healthy
- Ocular Surface Changes in Patients With Cystic Fibrosis
ClinicalTrials.gov Identifier: NCT00345280 - Not yet recruiting
Eye Manifestations
- Ocular Tolerance and IOP Effects of Zylet vs Tobradex
ClinicalTrials.gov Identifier: NCT00532961 - Completed
Ocular Inflammation
- Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00357292 - Completed
Eye Infections, Bacterial
- Oculusgen (Ologen) Collagen Matrix Safety and Effective Comparision With MMC in Glaucoma Surgery
ClinicalTrials.gov Identifier: NCT00538590 - Recruiting
Open Angle Glaucoma
- Oculusgen (Ologen) Glaucoma MMC Control in Estonia
ClinicalTrials.gov Identifier: NCT00524758 - Recruiting
Open Angle Glaucoma; Angle Closure Glaucoma; Uveitis Glaucoma; Young Age Glaucoma; Neovascular Glaucoma; High Risk Patient
- OculusGen-Glaucoma Historical Control Study in Taiwan
ClinicalTrials.gov Identifier: NCT00406822 - Recruiting
Glaucoma
- OculusGen-Phacotrabeculectomy Historical Control Study in India
ClinicalTrials.gov Identifier: NCT00477685 - Recruiting
Glaucoma; Cataract
- OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
ClinicalTrials.gov Identifier: NCT00449722 - Completed
Ulcerative Colitis
- Odense Androgen Study
ClinicalTrials.gov Identifier: NCT00150163 - Active, not recruiting
Bone Diseases; Lipid and glucose metabolism
- Odense Androgen Study in the Elderly
ClinicalTrials.gov Identifier: NCT00155961 - Completed
Bone Diseases; Metabolic Syndrome
- Odiparcil For The Prevention Of Venous Thromboembolism
ClinicalTrials.gov Identifier: NCT00244725 - Active, not recruiting
Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism
- Odiparcil QT Definitive Study
ClinicalTrials.gov Identifier: NCT00437242 - Terminated
Atrial Fibrillation
- ODYSSEY Study: Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00174863 - Completed
Prostatic Neoplasm
- Oestrogen Withdrawal in Hypopituitary Women
ClinicalTrials.gov Identifier: NCT00572390 - Completed
Hypopituitarism
- Ofatumumab (Humax-CD20) With CHOP in FL Patients
ClinicalTrials.gov Identifier: NCT00494780 - Recruiting
Follicular Lymphoma
- Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
ClinicalTrials.gov Identifier: NCT00410163 - Recruiting
B-Cell Chronic Lymphocytic Leukemia
- Off Label Use of INFLIXIMAB in Adult Patients With Severe Eosinophilic Esophagitis
ClinicalTrials.gov Identifier: NCT00523354 - Completed
Esophagitis
- Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy
ClinicalTrials.gov Identifier: NCT00344617 - Active, not recruiting
Choroidal Neovascularisation; Polypoidal Choroidal Vasculopathy
- Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department
ClinicalTrials.gov Identifier: NCT00380679 - Active, not recruiting
High Risk for Serious Influenza; High Risk for Pneumonia
- Office Practice Assessment of Carotid Atherosclerosis Using Handheld Ultrasound (OPACA) Study
ClinicalTrials.gov Identifier: NCT00258973 - Completed
Atherosclerosis
- Office-Based Asthma Screening Intervention
ClinicalTrials.gov Identifier: NCT00156468 - Completed
Asthma
- Official Record of Patients Diagnosed with Lymphangioleiomyomatosis (LAM)
ClinicalTrials.gov Identifier: NCT00001869 - Completed
Leiomyomatosis
- Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate
ClinicalTrials.gov Identifier: NCT00480376 - Not yet recruiting
Infection
- OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients with Neuronopathic Gaucher Disease
ClinicalTrials.gov Identifier: NCT00041535 - Active, not recruiting
Gaucher Disease
- OGT Spray in the Management of Xerostomia in the Elderly
ClinicalTrials.gov Identifier: NCT00350350 - Terminated
Xerostomia
- OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
ClinicalTrials.gov Identifier: NCT00471432 - Completed
Bladder Cancer; Breast Cancer; Kidney Cancer; Lung Cancer; Ovarian Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00258375 - Active, not recruiting
Breast Cancer
- Olanzapine Augmentation Therapy in Treatment-Resistant Depression: a Double-Blind Placebo-Controlled Trial
ClinicalTrials.gov Identifier: NCT00273624 - Recruiting
Therapy-Resistant Depression
- Olanzapine Compared to Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00094549 - Completed
Bipolar Disorder
- Olanzapine in Patients With Advanced Cancer and Weight Loss
ClinicalTrials.gov Identifier: NCT00489593 - Recruiting
Advanced Cancer; Weight Loss
- Olanzapine in Patients with Borderline Personality Disorder
ClinicalTrials.gov Identifier: NCT00091650 - Completed
Borderline Personality Disorder
- Olanzapine in the Treatment of Hair Pulling (Trichotillomania)
ClinicalTrials.gov Identifier: NCT00182507 - Completed
Trichotillomania
- Olanzapine in the Treatment of Patients With Anorexia Nervosa
ClinicalTrials.gov Identifier: NCT00260962 - Recruiting
Anorexia Nervosa
- Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00320489 - Recruiting
Schizophrenia
- Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania
ClinicalTrials.gov Identifier: NCT00190892 - Completed
Bipolar Disorder
- Olanzapine Treatment of Patients With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00510146 - Recruiting
Depression, Bipolar
- Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00034580 - Completed
Bipolar Disorder
- Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia
ClinicalTrials.gov Identifier: NCT00034801 - Completed
Depression; Schizophrenia; Schizoaffective Disorder
- Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
ClinicalTrials.gov Identifier: NCT00036088 - Completed
Schizophrenia
- Olanzapine versus Aripiprazole in the Treatment of Acutely Ill Patients with Schizophrenia
ClinicalTrials.gov Identifier: NCT00103571 - Completed
Schizophrenia
- Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
ClinicalTrials.gov Identifier: NCT00179231 - Completed
Schizophrenia; Schizoaffective Disorder
- Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00485680 - Completed
Bipolar Disorder
- Olanzapine versus Placebo in the Treatment of Adolescents with Schizophrenia
ClinicalTrials.gov Identifier: NCT00051298 - Completed
Schizophrenia
- Olanzapine Versus Placebo in the Treatment of Mania in Adolescents with Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00050206 - Completed
Bipolar Disorder
- Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression
ClinicalTrials.gov Identifier: NCT00485771 - Completed
Bipolar Disorder
- Older Adult Training Study With Creatine and CLA
ClinicalTrials.gov Identifier: NCT00473902 - Completed
Sarcopenia
- Older Men and Testosterone
ClinicalTrials.gov Identifier: NCT00119483 - Active, not recruiting
Hypogonadism
- OLES
ClinicalTrials.gov Identifier: NCT00172133 - Active, not recruiting
Osteoporosis
- Olestra Containing Foods and Weight Loss and Weight Maintenance
ClinicalTrials.gov Identifier: NCT00198965 - Completed
Obesity
- Oligodendrocyte Progenitor Cell Culture From Human Brain
ClinicalTrials.gov Identifier: NCT00283023 - Not yet recruiting
Demyelinating Diseases
- Olive Oil With Omega 3 to Treat Stasis Dermatitis
ClinicalTrials.gov Identifier: NCT00421161 - Not yet recruiting
Dermatitis
- Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
ClinicalTrials.gov Identifier: NCT00139698 - Completed
Essential Hypertension
- Olmesartan and an Add-on Treatment in Patients With Mild to Moderate Hypertension
ClinicalTrials.gov Identifier: NCT00311155 - Recruiting
Essential Hypertension
- OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
ClinicalTrials.gov Identifier: NCT00134160 - Active, not recruiting
Aged; Hypertension; Diabetes Mellitus Type 2; Cardiovascular Diseases
- Olmesartan as an Add-on to Amlodipine in Hypertension
ClinicalTrials.gov Identifier: NCT00220233 - Completed
Essential Hypertension
- Olmesartan in Essential Hypertension
ClinicalTrials.gov Identifier: NCT00185172 - Active, not recruiting
Essential Hypertension
- Olmesartan Medoxomil and Diabetic Nephropathy
ClinicalTrials.gov Identifier: NCT00362960 - Completed
Type 2 Diabetes Mellitus; Diabetic Nephropathy; Proteinuria; Renal Disease
- Olmesartan Medoxomil in Atherosclerosis
ClinicalTrials.gov Identifier: NCT00185185 - Completed
Essential Hypertension; Atherosclerotic Cardiovascular Disease
- Olmesartan Medoxomil in Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00185159 - Active, not recruiting
Diabetes Mellitus, Type 2; Cardiovascular Disease; Kidney Disease
- Olmesartan Medoxomil in Hypertension and Renal Impairment
ClinicalTrials.gov Identifier: NCT00151827 - Completed
Essential Hypertension; Renal impairment
- Olmesartan Pediatric Pharmacokinetic (PK) Study
ClinicalTrials.gov Identifier: NCT00151814 - Recruiting
Hypertension
- Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension
ClinicalTrials.gov Identifier: NCT00441350 - Not yet recruiting
Hypertension
- Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital
ClinicalTrials.gov Identifier: NCT00321035 - Active, not recruiting
Glaucoma; Pterygium
- Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital
ClinicalTrials.gov Identifier: NCT00320762 - Active, not recruiting
Glaucoma; Pterygium
- Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital
ClinicalTrials.gov Identifier: NCT00320957 - Completed
Glaucomas; Pterygium
- Ologen (OculusGen)-Glaucoma Case Control Trial in India
ClinicalTrials.gov Identifier: NCT00448929 - Recruiting
Glaucoma
- Ologen (OculusGen)-Glaucoma MMC Control in Pakistan
ClinicalTrials.gov Identifier: NCT00472810 - Recruiting
Glaucoma; Trabeculectomy
- Ologen (OculusGen)-Glaucoma MMC Control Trial in India
ClinicalTrials.gov Identifier: NCT00449098 - Recruiting
Glaucoma
- Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital
ClinicalTrials.gov Identifier: NCT00478790 - Recruiting
Glaucomas; Pterygium
- Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
ClinicalTrials.gov Identifier: NCT00331500 - Active, not recruiting
Allergic Conjunctivitis
- Oltipraz in the Prevention of Lung Cancer in People Who Smoke
ClinicalTrials.gov Identifier: NCT00006457 - Active, not recruiting
Small Cell Lung Cancer; prevention of lung cancer; Non-small cell lung cancer
- Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment
ClinicalTrials.gov Identifier: NCT00296153 - Recruiting
Human Immunodeficiency Virus; Ischemic Heart Disease
- Omacor and Placebo in Carotid Plaque Stability
ClinicalTrials.gov Identifier: NCT00294216 - Completed
Cardiovascular Disease
- Omacor for Perimenopausal Depression
ClinicalTrials.gov Identifier: NCT00517972 - Recruiting
Depression
- Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00328536 - Not yet recruiting
Atherosclerosis; Type 2 Diabetes Mellitus
- Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
ClinicalTrials.gov Identifier: NCT00257283 - Completed
Kidney Failure, Chronic
- Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
ClinicalTrials.gov Identifier: NCT00078195 - Completed
Hay Fever; Hypersensitivity; Allergy; Rhinitis
- Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma
ClinicalTrials.gov Identifier: NCT00264849 - Recruiting
Asthma
- Omalizumab to Treat Eosinophilic Gastroenteritis
ClinicalTrials.gov Identifier: NCT00084097 - Active, not recruiting
Gastroenteritis
- Omalizumab to Treat Hyper-IgE (Job's) Syndrome
ClinicalTrials.gov Identifier: NCT00260702 - Recruiting
Hyper-IgE Syndrome; Job's Syndrome
- Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
ClinicalTrials.gov Identifier: NCT00567476 - Recruiting
Asthma
- Omega 3 Fatty Acids and Atrial Fibrillation
ClinicalTrials.gov Identifier: NCT00508248 - Recruiting
Atrial Fibrillation
- Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
ClinicalTrials.gov Identifier: NCT00467818 - Recruiting
Autism
- Omega 3 PUFAs and Microvolt TWA in Patients With Ventricular Arrhythmia
ClinicalTrials.gov Identifier: NCT00507390 - Recruiting
Defibrillators, Implantable
- Omega Interferon Alone or in Combination with Ribavirin in Subjects with Hepatitis C
ClinicalTrials.gov Identifier: NCT00097045 - Completed
Hepatitis C
- Omega-3 and Vitamin E Supplementation in Patients With Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00399282 - Completed
Rheumatoid Arthritis
- Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment
ClinicalTrials.gov Identifier: NCT00558532 - Recruiting
Morbid Obesity; Cardiovascular Disease; Fatty Acid Levels
- Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies
ClinicalTrials.gov Identifier: NCT00135902 - Active, not recruiting
Preterm Birth; Pregnancy
- Omega-3 Fatty Acid Treatment in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00360906 - Completed
Relapsing-Remitting Multiple Sclerosis
- Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery
ClinicalTrials.gov Identifier: NCT00488904 - Recruiting
Complications; Infections; Colorectal Cancer
- Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
ClinicalTrials.gov Identifier: NCT00511810 - Recruiting
Major Depressive Disorder; Neuroimaging
- Omega-3 Fatty Acids for High Triglycerides in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00346697 - Recruiting
HIV; AIDS; Dyslipidemia; Hypertriglyceridemia
- Omega-3 Fatty Acids for Treating Adults With Major Depression
ClinicalTrials.gov Identifier: NCT00517036 - Recruiting
Depression
- Omega-3 Fatty Acids in Adolescent Depression
ClinicalTrials.gov Identifier: NCT00312897 - Recruiting
Adolescent Depression
- Omega-3 fatty acids in bipolar disorder
ClinicalTrials.gov Identifier: NCT00010868 - Completed
Bipolar Disorder
- Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00252486 - Active, not recruiting
Bipolar Disorder
- Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer
ClinicalTrials.gov Identifier: NCT00114296 - Active, not recruiting
Breast Cancer
- Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
ClinicalTrials.gov Identifier: NCT00001146 - Completed
Bipolar Disorder; Involutional Depression; Mood Disorder
- Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss
ClinicalTrials.gov Identifier: NCT00003077 - Completed
Leukemia; Lymphoma; Multiple Myeloma
- Omega-3 Fatty Acids that Affect the Immune System in Kidney Transplant Patients
ClinicalTrials.gov Identifier: NCT00047983 - Completed
Kidney Diseases
- Omega-3 for Depression and Other Cardiac Risk Factors
ClinicalTrials.gov Identifier: NCT00116857 - Recruiting
Cardiovascular Diseases; Depression; Heart Diseases; Myocardial Infarction; Angina, Unstable
- Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
ClinicalTrials.gov Identifier: NCT00149409 - Recruiting
Chronic Heart Failure
- Omega-Three Fatty Acids for the Prevention of Atrial Fibrillation After Cardiac Surgery
ClinicalTrials.gov Identifier: NCT00446966 - Recruiting
Atrial Fibrillation
- OmegAD (Omega-3 and Alzheimer's Disease)
ClinicalTrials.gov Identifier: NCT00211159 - Completed
Alzheimer's Disease
- Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.
ClinicalTrials.gov Identifier: NCT00172198 - Recruiting
Critical Ill Patients in SICU
- Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial)
ClinicalTrials.gov Identifier: NCT00412256 - Completed
Rheumatoid Arthritis
- Omentectomy for the Treatment of Diabetes Mellitus Type 2
ClinicalTrials.gov Identifier: NCT00270439 - Active, not recruiting
Diabetes Mellitus Type 2; Dyslipidemia; Hypercholesterolemia; Obesity
- Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplements and/or Garlic Supplements in Preventing Stomach Cancer in Patients With Precancerous Stomach Lesions
ClinicalTrials.gov Identifier: NCT00134121 - Active, not recruiting
Gastric Cancer; Precancerous Condition
- Omeprazole and Bortezomib in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00107302 - Recruiting
adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; indolent or aggressive adult non-Hodgkin's lymphoma
- Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-Adjusted Dosing
ClinicalTrials.gov Identifier: NCT00537732 - Recruiting
Gastroesophageal Reflux
- OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.
ClinicalTrials.gov Identifier: NCT00277524 - Active, not recruiting
Tachycardia, Ventricular; Heart Failure, Congestive; Ventricular Fibrillation; Ventricular Dysfunction; Bradycardia
- Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT
ClinicalTrials.gov Identifier: NCT00478556 - Recruiting
Healthy
- Omr-IgG-am (Trademark) for Treating Patients with or at High Risk for West Nile Virus Disease
ClinicalTrials.gov Identifier: NCT00069316 - Active, not recruiting
West Nile Virus
- On Demand Treatment of Reflux Disease
ClinicalTrials.gov Identifier: NCT00184522 - Completed
Gastroesophageal Reflux
- On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)
ClinicalTrials.gov Identifier: NCT00564460 - Not yet recruiting
Benign Prostatic Hyperplasia
- On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication
ClinicalTrials.gov Identifier: NCT00161096 - Active, not recruiting
Chronic Use of Acid Suppressive Medication; GORD; GERD; Reflux; Peptic Ulcer
- Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
ClinicalTrials.gov Identifier: NCT00256828 - Completed
HIV Infections
- Once Daily 3TC, Efavirenz and ddI for HIV Infection
ClinicalTrials.gov Identifier: NCT00214435 - Recruiting
HIV Infection; AIDS
- Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART
ClinicalTrials.gov Identifier: NCT00196612 - Completed
HIV Infections
- Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
ClinicalTrials.gov Identifier: NCT00413374 - Recruiting
Deep Vein Thrombosis; Pulmonary Embolism
- Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis
ClinicalTrials.gov Identifier: NCT00343850 - Terminated
Ulcerative Colitis
- Once Weekly Parathyroid Hormone for Osteoporosis
ClinicalTrials.gov Identifier: NCT00065637 - Completed
Osteopenia; Osteoporosis
- Once Weekly Radiation for Lung Cancer With Chemotherapy
ClinicalTrials.gov Identifier: NCT00256789 - Recruiting
Carcinoma, Non-Small-Cell Lung
- Once-A-Month Steroid Treatment for Patients with Focal Segmental Glomerulosclerosis
ClinicalTrials.gov Identifier: NCT00004990 - Completed
Glomerulonephritis; Nephrotic Syndrome
- Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children
ClinicalTrials.gov Identifier: NCT00129688 - Completed
Neutropenia; Cancer; Fever
- Once-Daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
ClinicalTrials.gov Identifier: NCT00532168 - Recruiting
HIV Infections
- Once-Daily Drug Regimen for HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00001968 - Completed
Acquired Immunodeficiency Syndrome; HIV Infections
- Once-Daily HAART Regimen Administration in HIV-1 Infected Children in Burkina Faso
ClinicalTrials.gov Identifier: NCT00122538 - Active, not recruiting
HIV Infection; AIDS
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)
ClinicalTrials.gov Identifier: NCT00289198 - Completed
Perennial Allergic Rhinitis
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
ClinicalTrials.gov Identifier: NCT00197262 - Active, not recruiting
Rhinitis
- Once-Daily Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis. The Einstein-DVT Dose-Finding Study
ClinicalTrials.gov Identifier: NCT00395772 - Completed
Treatment of Venous Thromboembolism
- Once-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-limited Conditions
ClinicalTrials.gov Identifier: NCT00084136 - Active, not recruiting
HIV Infections
- ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
ClinicalTrials.gov Identifier: NCT00003034 - Active, not recruiting
localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
- OncoVEX GM-CSF in Patients With Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00402025 - Recruiting
Pancreatic Cancer
- Ondansetron for the Treatment of Cocaine Dependence - 1
ClinicalTrials.gov Identifier: NCT00033085 - Active, not recruiting
Cocaine-Related Disorders; Drug Administration Schedule
- Ondansetron for the Treatment of Methamphetamine Dependence - 1
ClinicalTrials.gov Identifier: NCT00040053 - Active, not recruiting
Amphetamine-Related Disorders
- Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
ClinicalTrials.gov Identifier: NCT00006348 - Active, not recruiting
Leukemia; Lymphoma; Multiple Myeloma; Eye Cancer
- Ondansetron Reduce Vomiting Associated With Ketamine PSA
ClinicalTrials.gov Identifier: NCT00387556 - Completed
Conscious Sedation
- Ondansetron Treatment for Alcoholism
ClinicalTrials.gov Identifier: NCT00000443 - Completed
Alcoholism
- Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen
ClinicalTrials.gov Identifier: NCT00016380 - Active, not recruiting
Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; nausea and vomiting; Quality of Life
- One Hour Preoperative Gatifloxacin
ClinicalTrials.gov Identifier: NCT00350363 - Recruiting
Ophthalmic Surgery
- One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine
ClinicalTrials.gov Identifier: NCT00142337 - Active, not recruiting
HIV; Postpartum Period
- One Tablet Sublingual Immunotherapy in Adults with Grass Pollen Rhinoconjunctivitis
ClinicalTrials.gov Identifier: NCT00146991 - Terminated
Seasonal Allergic Rhinoconjunctivitis
- One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
ClinicalTrials.gov Identifier: NCT00358397 - Recruiting
Tumors
- One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
ClinicalTrials.gov Identifier: NCT00465855 - Recruiting
Carbon Monoxide Poisoning
- One Week PTHrP IV Dose Escalation Study
ClinicalTrials.gov Identifier: NCT00580788 - Not yet recruiting
Osteoporosis; Humoral Hypercalcemia of Malignancy; Hyperparathyroidism
- One Year Drug Treatment in First-Episode Schizophrenia
ClinicalTrials.gov Identifier: NCT00159081 - Active, not recruiting
Schizophrenia
- One Year Extension Study To Protocol C2/5/TZ:MS-05
ClinicalTrials.gov Identifier: NCT00464958 - Not yet recruiting
Spasticity; Fatigue
- One Year Glargine Treatment in CFRD Children and Adolescents
ClinicalTrials.gov Identifier: NCT00483769 - Completed
Cystic Fibrosis; Glucose Metabolism Disorders
- One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00409851 - Completed
Hypertension
- One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)
ClinicalTrials.gov Identifier: NCT00246467 - Active, not recruiting
Plague
- One-Lung Ventilation: Expression of Pulmonary Inflammatory Mediators
ClinicalTrials.gov Identifier: NCT00515905 - Recruiting
Thoracic Surgery With One-Lung Ventilation
- One-Year Prospective Observational Study of BMI Change Effect of 5-Alpha Reductase Inhibitor in Korean BPH Patients
ClinicalTrials.gov Identifier: NCT00472251 - Recruiting
Benign Prostatic Hyperplasia
- Onercept in the Treatment and Re-Treatment of Subjects with Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov Identifier: NCT00090129 - Terminated
Psoriatic Arthritis
- Online Caregiver Psychoeducation and Support for Alzheimer's
ClinicalTrials.gov Identifier: NCT00416078 - Recruiting
Alzheimer's Disease
- Online Family Support and Education for Schizophrenia
ClinicalTrials.gov Identifier: NCT00046085 - Active, not recruiting
Schizophrenia; Schizoaffective Disorder
- Online HIV Prevention Vignette Evaluation
ClinicalTrials.gov Identifier: NCT00249327 - Completed
HIV Infections
- Online Survey on Computer Password Usage
ClinicalTrials.gov Identifier: NCT00357136 - Recruiting
Carpal Tunnel Syndrome
- ONO-7436 Phase II Study in Japan
ClinicalTrials.gov Identifier: NCT00212602 - Completed
Malignant Tumor
- Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-Release) As Add-on Therapy To L-Dopa In Parkinson's
ClinicalTrials.gov Identifier: NCT00363727 - Active, not recruiting
Parkinson's Disease; Dyskinesias
- Onsite versus Referral Models of Primary Care for Substance Abusing Patients
ClinicalTrials.gov Identifier: NCT00057096 - Completed
Substance Abuse
- OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation
ClinicalTrials.gov Identifier: NCT00439127 - Completed
Differentiated Thyroid Carcinoma
- Ontak (Denileukin Diftitox) in Patients With SM
ClinicalTrials.gov Identifier: NCT00493129 - Completed
Leukemia; Systemic Mastocytosis
- ONTAK to Estimate Response in Cutaneous T-Cell Lymphoma According to CD25 Status
ClinicalTrials.gov Identifier: NCT00279396 - Active, not recruiting
Non-Hodgkin's Lymphoma
- ONTARGET: ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria Parallel Trial. TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease Trial.
ClinicalTrials.gov Identifier: NCT00153101 - Active, not recruiting
Cardiovascular Diseases
- Ontario ICU Clinical Best Practices Demonstration Project
ClinicalTrials.gov Identifier: NCT00332982 - Completed
Ventilator Acquired Pneumonia; Catheter Related Blood Stream Infections; Pressure Ulcer Prophylaxis; DVT Prophylaxis; Restrictive Blood Transfusion Strategy; Daily Spontaeous Breathing Trials
- Ontario MDCT Coronary Angiography Study (OMCAS)
ClinicalTrials.gov Identifier: NCT00371891 - Recruiting
Coronary Arteriosclerosis; Cardiomyopathies; Heart Defects, Congenital; Heart Valve Diseases
- Onychomycosis: Diagnosis and Prevalence in Diabetic Neuropathic Patients
ClinicalTrials.gov Identifier: NCT00525187 - Completed
Prevalence of Onychomycosis; Diabetic Neuropathic Patients; Diagnostic of Onychomycosis; Patients Clinically Suspected of Onychomycosis; Reliability of the Diagnosis of Onychomycosis
- ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00006106 - Recruiting
lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
- OPAL - Insulin Glulisine, Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00272012 - Completed
Diabetes Mellitus Type 2
- OPALS Cardiac Arrest Database (OCAD)
ClinicalTrials.gov Identifier: NCT00300703 - Recruiting
Cardiac Arrest
- OPALS Critical Care Sub-Studies
ClinicalTrials.gov Identifier: NCT00212953 - Active, not recruiting
Cardiac Arrest
- OPALS Pediatric Study
ClinicalTrials.gov Identifier: NCT00298532 - Active, not recruiting
Seizure
- Open Label Arimidex in Gynecomastia
ClinicalTrials.gov Identifier: NCT00241436 - Completed
Gynecomastia
- Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
ClinicalTrials.gov Identifier: NCT00432653 - Not yet recruiting
Ankylosing Spondylitis
- Open Label Comparative Study on Celecoxib Efficacy and Safety vs Non-Selective NSAID in Acute Pain Due to Ankle Sprain
ClinicalTrials.gov Identifier: NCT00446797 - Recruiting
Sprains and Strains
- Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities
ClinicalTrials.gov Identifier: NCT00311649 - Active, not recruiting
Influenza
- Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
ClinicalTrials.gov Identifier: NCT00148330 - Active, not recruiting
Diabetic macular oedema
- Open Label Extension of ISIS 301012 to Treat Familial Hypercholesterolemia
ClinicalTrials.gov Identifier: NCT00477594 - Recruiting
Familial Hypercholesterolemia
- Open Label Extension Study Evaluating Sildenafil Citrate When Used In Combination with Epoprostenol In PAH
ClinicalTrials.gov Identifier: NCT00147641 - Active, not recruiting
Pulmonary Hypertension
- Open Label Extension Study of AMG 531 in Japanese Subjects With ITP
ClinicalTrials.gov Identifier: NCT00440037 - Recruiting
Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
- Open Label Extension Study of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
ClinicalTrials.gov Identifier: NCT00116688 - Recruiting
Thrombocytopenia
- Open Label Extension Study of Bifeprunox
ClinicalTrials.gov Identifier: NCT00366171 - Completed
Schizophrenia
- Open Label Extension Study of Eculizumab in Patients with Transfusion Dependent PNH.
ClinicalTrials.gov Identifier: NCT00122317 - Active, not recruiting
Transfusion dependent, hemolytic paroxysmal nocturnal hemoglobinuria.
- Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00139594 - Completed
Bipolar Disorder
- Open Label Extension Study to Evaluate the Long Term Use of Valsartan in 1-5 Year Old Hypertensive Children
ClinicalTrials.gov Identifier: NCT00457626 - Recruiting
Hypertension
- Open Label Extension Trial for Rotigotine in Advanced Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00501969 - Active, not recruiting
Advanced Parkinson's Disease
- Open Label Follow up Trial of Rotigotine in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00505687 - Active, not recruiting
Parkinson's Disease
- Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
ClinicalTrials.gov Identifier: NCT00002025 - Completed
Cytomegalovirus Infections; Cytomegalovirus Retinitis; HIV Infections
- Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00260793 - Recruiting
Parkinson's Disease
- Open Label INCB018424 in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
ClinicalTrials.gov Identifier: NCT00509899 - Recruiting
Myelofibrosis; Polycythemia Vera; Thrombocytosis
- Open Label Long Term Follow up Study With Certolizumab Pegol for Patients Completing C87042
ClinicalTrials.gov Identifier: NCT00333788 - Recruiting
Crohn Disease
- Open Label Long-Term Safety Study of AT1001 in Patients With Fabry Disease Who Have Completed a Previous AT1001 Study
ClinicalTrials.gov Identifier: NCT00526071 - Recruiting
Fabry Disease
- Open Label Long-Term Safety Study of CDP870 (Certolizumab Pegol) for Patients With Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00160693 - Active, not recruiting
Rheumatoid Arthritis
- Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease
ClinicalTrials.gov Identifier: NCT00280956 - Completed
Crohn's Disease
- Open Label Non-Comparative Clinical Trial of Tigecycline in Patients With Catheter Infection
ClinicalTrials.gov Identifier: NCT00419991 - Recruiting
Staphylococcal Infections
- Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer
ClinicalTrials.gov Identifier: NCT00582985 - Recruiting
Cancer; Neoplasm Metastasis
- Open Label Phase 3 Study of NABI-IGIV 10% [(HUMAN)] In Subjects With Primary Immune Deficiency Disorders (PIDD)
ClinicalTrials.gov Identifier: NCT00538915 - Recruiting
Primary Immune Deficiency Disorders; Antibody Deficiency Syndromes
- Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00280397 - Recruiting
Cancer
- Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms
ClinicalTrials.gov Identifier: NCT00407498 - Recruiting
Neoplasm
- Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00000695 - Completed
Sarcoma, Kaposi; HIV Infections
- Open Label Phase III Duloxetine Study for Stress Urinary Incontinence
ClinicalTrials.gov Identifier: NCT00191204 - Completed
Urinary Incontinence Stress
- Open Label Randomized Neoadjuvant Chemotherapy (Paclitaxel Followed by FEC) Versus Paclitaxel and RAD001 Followed by FEC in Women With Triple Receptor-Negative Breast Cancer
ClinicalTrials.gov Identifier: NCT00499603 - Recruiting
Breast Cancer
- Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients with Epilepsy
ClinicalTrials.gov Identifier: NCT00160628 - Completed
Epilepsy, Partial
- Open Label Safety and Efficacy Study of Levetiracetam in Patients with Epilepsy
ClinicalTrials.gov Identifier: NCT00160654 - Completed
Epilepsy, Partial
- Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With HIV Neuropathy
ClinicalTrials.gov Identifier: NCT00264875 - Recruiting
Peripheral Neuropathy; HIV
- Open Label Safety Efficacy Study of Levetiracetam in Patients with Epilepsy
ClinicalTrials.gov Identifier: NCT00152373 - Completed
Epilepsy, Partial
- Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients with Refractory Epilepsy.
ClinicalTrials.gov Identifier: NCT00175864 - Not yet recruiting
Epilepsy
- Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
ClinicalTrials.gov Identifier: NCT00330785 - Completed
Hypertension; Dyslipidemia
- Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-Esophageal Reflux Disease (GERD) Patients With Night-Time Heartburn Symptoms.
ClinicalTrials.gov Identifier: NCT00553449 - Active, not recruiting
Heartburn; Gastroesophageal Reflux
- Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00432068 - Recruiting
Healthy
- Open Label Study of Adalimumab in Subjects Who Have a Sub-Optimal Response to Systemic Therapy or Phototherapy
ClinicalTrials.gov Identifier: NCT00566722 - Not yet recruiting
Psoriasis
- Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain
ClinicalTrials.gov Identifier: NCT00425230 - Recruiting
Chronic Phantom Limb Pain
- Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00325286 - Active, not recruiting
Bipolar Disorder
- Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting
ClinicalTrials.gov Identifier: NCT00509990 - Completed
Atopic Dermatitis
- Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections
ClinicalTrials.gov Identifier: NCT00034658 - Completed
Mycoses
- Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections
ClinicalTrials.gov Identifier: NCT00034632 - Completed
Mycoses
- Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole
ClinicalTrials.gov Identifier: NCT00237224 - Terminated
Breast Cancer
- Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension
ClinicalTrials.gov Identifier: NCT00454207 - Recruiting
Pulmonary Hypertension
- Open Label Study of Subcutaneous Homoharringtonine in Patients With Advanced CML
ClinicalTrials.gov Identifier: NCT00462943 - Recruiting
Chronic Myelogenous Leukemia
- Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm
ClinicalTrials.gov Identifier: NCT00397670 - Completed
Contraception
- Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation
ClinicalTrials.gov Identifier: NCT00298818 - Active, not recruiting
Epilepsy; Mental Retardation; Developmental Disabilities
- Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
ClinicalTrials.gov Identifier: NCT00174304 - Completed
Hypertension; Hyperlipidemia
- Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250 µg in Patients of Chinese Origin With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00370071 - Recruiting
Multiple Sclerosis
- Open Label Study to Evaluate the Safety of Twice Daily Oral Carvedilol
ClinicalTrials.gov Identifier: NCT00129363 - Active, not recruiting
Congestive Heart Failure
- Open Label Study with

Not Signed In -